Search
Search
About
Log in
Join
Experiences with
Enzalutamide
Posts
Communities
781 public posts
Filter results
FYI: New data on progression of visceral mets without PSA progression (discordance) and ARAT/docetaxel therapy
., abiraterone and
enzalutamide
) may be susceptible to discordant progression. With the incorporation of early ARAT in SOC, we may see this number rise.
., abiraterone and
enzalutamide
) may be susceptible to discordant progression. With the incorporation of early ARAT in SOC, we may see this number rise.
SeosamhM
in
Advanced Prostate Cancer
9 months ago
PCa spread to Liver
He is currently on
Enzalutamide
+ hormone injections(monthly) and has had 6 rounds of chemo (Docetaxel) finished in first week of March 2023.
He is currently on
Enzalutamide
+ hormone injections(monthly) and has had 6 rounds of chemo (Docetaxel) finished in first week of March 2023.
A-rat-22
in
Advanced Prostate Cancer
11 months ago
Rising PSA Again! What Next? Any Thoughts?
Try to get on a drug such
enzalutamide
, apalutamide, etc.? Any thoughts that I could discuss with my Oncologist?
Try to get on a drug such
enzalutamide
, apalutamide, etc.? Any thoughts that I could discuss with my Oncologist?
MGBman
in
Advanced Prostate Cancer
1 year ago
Want to take advantage of all our features? Just log in!
Log in
or
Join
Clarification on ALP and LDH markers
Has been on
enzalutamide
after reoccurance until Dec 20, 2022 when he came off of it to start chemo again (docetaxel 10 rounds + prednisone is the plan). In early Oct, bone scan was clear and CT scan revealed prostate tumour and some lymph involvement.
Has been on
enzalutamide
after reoccurance until Dec 20, 2022 when he came off of it to start chemo again (docetaxel 10 rounds + prednisone is the plan). In early Oct, bone scan was clear and CT scan revealed prostate tumour and some lymph involvement.
fmoser
in
Advanced Prostate Cancer
1 year ago
Squalene Monooxygenase
"Furthermore, SQLE was essential for proliferation of AR-positive PCa cell lines, including abiraterone or
enzalutamide
resistant derivatives, and blocked transactivation of the AR pathway. ...
"Furthermore, SQLE was essential for proliferation of AR-positive PCa cell lines, including abiraterone or
enzalutamide
resistant derivatives, and blocked transactivation of the AR pathway. ...
pjoshea13
in
Fight Prostate Cancer
1 year ago
Lu-177 PNT2002 SPLASH trial
The randomized study (32 weeks) will have arm A and arm B (abiraterone or
enzalutamide
) with crossover eligibility. I am concerned if I get assigned to arm B and moving the possible treatment well too late down the road if I change as requested from Abiraterone to
Enzalutamide
.
The randomized study (32 weeks) will have arm A and arm B (abiraterone or
enzalutamide
) with crossover eligibility. I am concerned if I get assigned to arm B and moving the possible treatment well too late down the road if I change as requested from Abiraterone to
Enzalutamide
.
Ollie1948
in
Advanced Prostate Cancer
2 years ago
I would like to connect with fellow warriors that are HSPC and on Darolutamide to discuss Time to Failure, early detection assays etc...
Second generation androgen receptor antagonists and challenges in prostate cancer treatment https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304354/ " The utility of these agents has expanded with the emergence of second-generation AR antagonists, which began with the approval of
enzalutamide
in 2012
Second generation androgen receptor antagonists and challenges in prostate cancer treatment https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304354/ " The utility of these agents has expanded with the emergence of second-generation AR antagonists, which began with the approval of
enzalutamide
in 2012
KocoPr
in
Advanced Prostate Cancer
1 year ago
Pluvicto increases radiographic progression-free survival (rPFS) before chemo
https://clinicaltrials.gov/ct2/show/NCT04689828 It tested whether giving Pluvicto increases radiographic progression-free survival (rPFS) in men who: (1) have failed one of the second-line hormonals (abiraterone,
enzalutamide
, darolutamide, or apalutamide) (2) have not had taxane chemo (3) are metastatic
https://clinicaltrials.gov/ct2/show/NCT04689828 It tested whether giving Pluvicto increases radiographic progression-free survival (rPFS) in men who: (1) have failed one of the second-line hormonals (abiraterone,
enzalutamide
, darolutamide, or apalutamide) (2) have not had taxane chemo (3) are metastatic
Tall_Allen
in
Advanced Prostate Cancer
1 year ago
CCS 1477 3rd generation AR
it looks as though they’ve created a 3rd generation AR now.For when Aberaterone /
Enzalutamide
runs out of steam. Can a drug be fast tracked onto the market at a 3 year point or do the trials need at least 5 years before being approved does anyone know
it looks as though they’ve created a 3rd generation AR now.For when Aberaterone /
Enzalutamide
runs out of steam. Can a drug be fast tracked onto the market at a 3 year point or do the trials need at least 5 years before being approved does anyone know
Farn
in
Advanced Prostate Cancer
2 years ago
test Enzalutamide or Lu 177 for the first line therapy?
I wonder what is the best treatment to test lowering PSA now,
Enzalutamide
or Lu 177? I appreciate any idea.
I wonder what is the best treatment to test lowering PSA now,
Enzalutamide
or Lu 177? I appreciate any idea.
Samani
in
Advanced Prostate Cancer
2 years ago
Xtandi question
I am interested in hearing from anyone with experience in taking XTANDI® (
enzalutamide
). Has anyone else had an issue with TGA... Transient Global Amnesia? My husband has been on Xtandi for 6 weeks and has been in two different hospitals this last week.
I am interested in hearing from anyone with experience in taking XTANDI® (
enzalutamide
). Has anyone else had an issue with TGA... Transient Global Amnesia? My husband has been on Xtandi for 6 weeks and has been in two different hospitals this last week.
September221
in
Advanced Prostate Cancer
1 year ago
Docetaxel Extends Enzalutamide Effectiveness
This is our first proof that resistance to
enzalutamide
can be reduced with docetaxel. It also shows that triplet therapy may be beneficial in patients who have already progressed to castration resistance. We would expect a larger effect if used at the first sign of castration resistance.
This is our first proof that resistance to
enzalutamide
can be reduced with docetaxel. It also shows that triplet therapy may be beneficial in patients who have already progressed to castration resistance. We would expect a larger effect if used at the first sign of castration resistance.
Tall_Allen
in
Advanced Prostate Cancer
2 years ago
Cabazitaxel Plus Enzalutamide
Wondering if anyone here has had this combo prescribed and what the results were. There was a phase 1 and phase 2 trial that proved the safety of this combination and they also saw a PSA response 30% or more in 30% of the patients who had previously been treated with Abiraterone. The patients that
Wondering if anyone here has had this combo prescribed and what the results were. There was a phase 1 and phase 2 trial that proved the safety of this combination and they also saw a PSA response 30% or more in 30% of the patients who had previously been treated with Abiraterone. The patients that
EdBacon
in
Advanced Prostate Cancer
2 years ago
What first?: Provenge or Nubeqa?
Recently approved agents include abiraterone acetate and
enzalutamide
with TAK-700 (orteronel) and lyase inhibitors rapidly approaching in the development pipeline..."
Recently approved agents include abiraterone acetate and
enzalutamide
with TAK-700 (orteronel) and lyase inhibitors rapidly approaching in the development pipeline..."
GeorgeGlass
in
Advanced Prostate Cancer
1 year ago
Gut Microbiome, ADT & Doxycycline
." ***" We hypothesized that oral androgen receptor axis-targeted therapies (ATT), including bicalutamide,
enzalutamide
, and abiraterone acetate, may be associated with compositional differences in the GI microbiota."
." ***" We hypothesized that oral androgen receptor axis-targeted therapies (ATT), including bicalutamide,
enzalutamide
, and abiraterone acetate, may be associated with compositional differences in the GI microbiota."
pca2004
in
Fight Prostate Cancer
1 year ago
Enzalutamide or abiraterone
What is the difference between these two drugs. Which one should I use. I know this was discussed in a post recently. My Oncologist would like me to start with one of these. I asked him this question and said abiraterone has less fatigue side effects. I will need to get blood work done every two weeks
What is the difference between these two drugs. Which one should I use. I know this was discussed in a post recently. My Oncologist would like me to start with one of these. I asked him this question and said abiraterone has less fatigue side effects. I will need to get blood work done every two weeks
Islandboy2021
in
Advanced Prostate Cancer
2 years ago
An update on Peter Mac and Lu-177
I just wanted to update on my previous post (https://healthunlocked.com/advanced-prostate-cancer/posts/149757852/update-on-failing-
enzalutamide
).
I just wanted to update on my previous post (https://healthunlocked.com/advanced-prostate-cancer/posts/149757852/update-on-failing-
enzalutamide
).
CrocodileShoes
in
Advanced Prostate Cancer
10 months ago
BATMAN
Post-BAT, the PSA50 and PSA90 responses to abiraterone or
enzalutamide
were 94.4% and 66.7%, respectively and median PFS was 20.6 months. Patients with peak PSA level of ≥9 ng/ml after BAT had median PFS of 20.6 months versus NR for those having PSA < 9 ng/ml (HR: 0.122, p < 0.001).
Post-BAT, the PSA50 and PSA90 responses to abiraterone or
enzalutamide
were 94.4% and 66.7%, respectively and median PFS was 20.6 months. Patients with peak PSA level of ≥9 ng/ml after BAT had median PFS of 20.6 months versus NR for those having PSA < 9 ng/ml (HR: 0.122, p < 0.001).
pca2004
in
Fight Prostate Cancer
1 year ago
EMBARK trial results reported
[/i] https://www.pfizer.com/news/press-release/press-release-detail/phase-3-study-shows-xtandir-
enzalutamide
-plus-leuprolide
[/i] https://www.pfizer.com/news/press-release/press-release-detail/phase-3-study-shows-xtandir-
enzalutamide
-plus-leuprolide
GP24
in
Advanced Prostate Cancer
1 year ago
Advice Please
Enzalutamide
failed after about 6 months. Started docetaxel on Aug 10/22. After 4 cycles, bone scan results, received today, indicate a mixed pattern of response i.e., while many lesions have improved there is also progression in certain lesions as well as new lesions.
Enzalutamide
failed after about 6 months. Started docetaxel on Aug 10/22. After 4 cycles, bone scan results, received today, indicate a mixed pattern of response i.e., while many lesions have improved there is also progression in certain lesions as well as new lesions.
Univs
in
Advanced Prostate Cancer
2 years ago
1
...
8
9
10
...
40
Next page
10
20
30
40
Filter results
Clear filters
Posted in
All communities
Advanced Prostate Cancer
714 results
Fight Prostate Cancer
51 results
Prostate Cancer Network
7 results
View top 10 communities
Sort by
Most Relevant
Newest